Belhaven Biopharma | Finanzwire

Basculer en Français

10443	Companies
219212	Keywords
148671	Articles
115954	Press releases

Home
Companies
Belhaven Biopharma

BRIEF

published on 07/09/2024 at 17:05, 1 year 10 months ago

Belhaven Biopharma Study Shows Promising Results for Nasal Epinephrine Delivery

Belhaven Biopharma Nasdepi Anaphylaxis Treatment Medical Research Nasal Epinephrine
PRESS RELEASE

published on 07/09/2024 at 17:00, 1 year 10 months ago

New Canine Study From Belhaven Biopharma Supports Dry Powder Nasal Epinephrine Delivery Solution
Belhaven Biopharma presents promising results of Nasdepi Canine Study at Respiratory Drug Delivery 2024, indicating faster & effective treatment for anaphylaxis. Intranasal dry powder epinephrine offers breakthrough prospects in emergency care for severe allergies

Belhaven Biopharma Anaphylaxis Treatment Nasdepi Canine Study Dry Powder Nasal Solution Respiratory Drug Delivery 2024
PRESS RELEASE

published on 02/08/2024 at 18:30, 2 years 3 months ago

Belhaven Biopharma Announces Groundbreaking Clinical Results for Nasdepi, the Revolutionary Nasal Dry Powder Epinephrine Product
Belhaven Biopharma shares positive results from Phase 1 clinical trial of Nasdepi, a nasal dry powder epinephrine device for treating anaphylaxis. Successful investor round and Series A financing on the horizon

Phase 1 Clinical Trial Series A Financing Belhaven Biopharma Nasdepi Anaphylaxis Treatment
PRESS RELEASE

published on 11/28/2023 at 19:30, 2 years 5 months ago

Belhaven Biopharma Achieves Significant Milestones in Advancing Nasdepi - a Revolutionary Nasal Dry Powder Epinephrine Product

Accesswire

Published on 05/22/2026 at 18:40, 2 hours 23 minutes ago

Vertical Announces Grant of Options
Published on 05/22/2026 at 14:04, 6 hours 59 minutes ago

Wi2Wi Corporation Announces First Quarter 2026 Financial Results (Unaudited)
Published on 05/22/2026 at 14:00, 7 hours 3 minutes ago

Imagine Health Achieves Teaching Facility Status Through University of Calgary Faculty Partnership
Published on 05/22/2026 at 14:00, 7 hours 3 minutes ago

CCL Industries Inc. Announces Renewal of Normal Course Issuer Bid and Approval of Automatic Securities Purchase Plan
Published on 05/22/2026 at 14:00, 7 hours 3 minutes ago

Dateline Appoints Alvarez & Marsal to Manage Colosseum Development

View all ACCESSWIRE

EQS Group

Published on 05/22/2026 at 19:51, 1 hour 12 minutes ago

Turkiye Garanti Bankasi A.S.: Brokerage Houses Warrants Redemption Prices
Published on 05/22/2026 at 18:33, 2 hours 30 minutes ago

Update on Coupon payment due on 23 May 2026 and Preparation of the Green Bond Restructuring
Published on 05/22/2026 at 18:30, 2 hours 33 minutes ago

Annual General Meeting of Curatis Holding AG approved all proposals of the Board of Directors
Published on 05/22/2026 at 18:29, 2 hours 34 minutes ago

Designated Person Notification
Published on 05/22/2026 at 17:18, 3 hours 45 minutes ago

Chief Human Resources Officer Dr. Astrid Fontaine’s contract extended

Les Echos

Published on 05/22/2026 at 18:05, 2 hours 58 minutes ago

Disclosure of transactions in own shares from May 18 to May 22, 2026
Published on 05/22/2026 at 12:52, 8 hours 11 minutes ago

Release from the Board of Directors - Shareholders’ Meeting of May 22, 2026
Published on 05/22/2026 at 08:30, 12 hours 33 minutes ago

Eiffage is building four solar power plants for the NOOR Atlas programme in Morocco
Published on 05/21/2026 at 17:50, 1 day 3 hours ago

CDA - H1 results 2025 2026
Published on 05/21/2026 at 17:45, 1 day 3 hours ago

CEGEDIM: DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS

View all LES ECHOS COMFI WIRE